Cisplatin inhibits MEK1/2
Cisplatin (cDDP) is known to bind to the CXXC motif of proteins containing a ferrodoxin-like fold but little is known about its ability to interact with other Cu-binding proteins. MEK1/2 has recently been identified as a Cu-dependent enzyme that does not contain a CXXC motif. We found that cDDP boun...
Main Authors: | Yamamoto, Tetsu, Tsigelny, Igor F., Götz, Andreas W., Howell, Stephen B. |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695133/ |
Similar Items
-
ETS-targeted therapy: can it substitute for MEK inhibitors?
by: Osamu Tetsu, et al.
Published: (2017-05-01) -
Inhibiting MEK in MAPK pathway-activated myeloma
by: Heuck, C J, et al.
Published: (2016) -
Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance
by: Ueyama, Atsunori, et al.
Published: (2016) -
Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells
by: Singh, Anjali, et al.
Published: (2015) -
Nuclear MEK1 Sequesters PPARγ and Bisects MEK1/ERK Signaling: A Non-Canonical Pathway of Retinoic Acid Inhibition of Adipocyte Differentiation
by: Dave, Sandeep, et al.
Published: (2014)